The MRFIT, HDFP and Oslo studies: the important data. Multiple Risk Factor Intervention Trial. Hypertension Detection and Follow-up Program
Svärdsudd, K.
Cardiologia 29(1-2): 53-62
1984
ISSN/ISBN: 0393-1978 PMID: 6398706 Document Number: 222227
Document emailed within 1 workday
Related Documents
Grimm, R.H.; Cohen, J.D.; Smith, W.M.; Falvo-Gerard, L.; Neaton, J.D. 1985: Hypertension management in the Multiple Risk Factor Intervention Trial (MRFIT). Six-year intervention results for men in special intervention and usual care groups Archives of Internal Medicine 145(7): 1191-1199Gotto, A.M. 1997: The Multiple Risk Factor Intervention Trial (MRFIT). a return to a landmark trial JAMA 277(7): 595-597
Brancati, F.L.; Whelton, P.K.; Randall, B.L.; Neaton, J.D.; Stamler, J.; Klag, M.J. 1997: Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial JAMA 278(23): 2069-2074
Walker, W.G.; Neaton, J.D.; Cutler, J.A.; Neuwirth, R.; Cohen, J.D. 1992: Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group JAMA 268(21): 3085-3091
1990: Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group JAMA 263(13): 1795-1801
Langford, H.G.; Blaufox, M.D.; Borhani, N.O.; Curb, J.D.; Molteni, A.; Schneider, K.A.; Pressel, S. 1987: Is thiazide-produced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program Archives of Internal Medicine 147(4): 645-649
Kramer, M.S.; Chalmers, B.; Hodnett, E.D.; Sevkovskaya, Z.; Dzikovich, I.; Shapiro, S.; Collet, J.P.; Vanilovich, I.; Mezen, I.; Ducruet, T.; Shishko, G.; Zubovich, V.; Mknuik, D.; Gluchanina, E.; Dombrovsky, V.; Ustinovitch, A.; Ko, T.; Bogdanovich, N.; Ovchinikova, L.; Helsing, E. 2000: Promotion of breastfeeding intervention trial (PROBIT): a cluster-randomized trial in the Republic of Belarus. Design, follow-up, and data validation Advances in Experimental Medicine and Biology 478: 327-345
de Simone, G.; Muiesan, M.L.; Ganau, A.; Longhini, C.; Verdecchia, P.; Palmieri, V.; Agabiti-Rosei, E.; Mancia, G. 1999: Reliability and limitations of echocardiographic measurement of left ventricular mass for risk stratification and follow-up in single patients: the RES trial. Working Group on Heart and Hypertension of the Italian Society of Hypertension. Reliability of M-mode Echocardiographic Studies Journal of hypertension 17(12 Pt 2): 1955-1963
Langford, H.G. 1984: The hypertension detection and follow-up program New York State Journal of Medicine 84(6): 287-288
Genest, J.; Boucher, R.; Kuchel, O.; Nowaczynski, W. 1973: Renin in hypertension: how important as a risk factor? Canadian Medical Association Journal 109(6): 475-478
Daugherty, S.A. 1983: Hypertension detection and follow-up program. Description of the enumerated and screened population Hypertension 5(6 Pt 2): Iv1
Mateus, P.S.; Bettencourt, N.; Dias, C.Costa.; Santos, L.; Adão, Lís.; Roberto, Jé.; Mateus, C.; Ribeiro, Jé.; Primo, Jão.; Simões, L.; Ribeiro, V.Gama.; Barros, H. 2005: Impact of a structured intensive follow-up program on the control of hypertension in coronary patients--a randomized trial Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 24(2): 223-227
Maxwell, M.H.; Fitzsimmons, E.; Harrist, R.; Hotchkiss, J.; Langford, H.G.; Payne, G.H.; Schneider, K.A.; Varaday, P. 1983: Hypertension detection and follow-up program. Baseline laboratory examination characteristics of the hypertensive participants Hypertension 5(6 Pt 2): Iv133-Iv159
Oberman, A.; Blaufox, M.D.; Entwisle, G.; Harrist, R. 1983: Hypertension detection and follow-up program. Baseline chest radiographic characteristics of the hypertensive participants Hypertension 5(6 Pt 2): Iv190-Iv200
Comberg, H.U.; Knowles, M.; Tyroler, H.A.; Heyden, S.; Hames, C.G.; Sabo, D. 1988: Status of patients seven years after completion of the hypertension detection and follow-up program in Evans County, Georgia Journal of the National Medical Association 80(12): 1285-1292
Belova, E.V.; Pereponov, I.P.; Ol'kha, R.P.; Zaev, A.P.; Polosova, T.A. 1993: Detection of risk factors for hemodynamic dysadaptation under physical loading by data of genetic studies (echocardiography data) (Part 2) Kardiologiia 33(8): 31-33
Low, W.H.H.; Seet, W.; A S, R.; Ng, K.K.; H, J.; Dan, S.P.; Teng, C.L.; Lee, V.K.M.; Chua, S.S.; M Y, F.A.; T, K.; Chee, W.S.S.; Goh, P.P.; M, Z.; Lim, T.O. 2013: Community-based cardiovascular Risk Factors Intervention Strategies (CORFIS) in managing hypertension: a pragmatic non-randomised controlled trial Medical Journal of Malaysia 68(2): 129-135
Steinbach, M.; Constantineanu, M.; Harnagea, P.; Theodorini, S.; Georgescu, M.; Mitu, S.; Tănăseanu, S.; Tănăsescu, C.; Teodorescu, S.; Voiculescu, M.; Voiosu, R.; Cucu, F.; Suciu, A.; Schioiu, L.; Ciobanu, F.; Chirulescu, Z.; Schiau, M.; Cherciu, M.; Stoica, V.; David, D.; Stănescu, C.; Stefănescu, S.; Ionescu, A. 1982: The Bucharest multifactorial prevention trial of coronary heart disease. General methodology and risk factor correction after five year follow-up (1971-1977) Medecine Interne 20(2): 117-136
Gafarov, V.V.; Gromova, E.A.; Gagulin, I.V.; Gafarova, A.V. 2006: Effects of hostility on the risk of arterial hypertension, myocardial infarction, stroke in a sample of males aged 25-64 years (epidemiological trial on the base of WHO program MONICA) Terapevticheskii Arkhiv 78(9): 17-21
Murphy, D.H. 1985: Treatment of mild hypertension: new results on MRFIT, sodium American Pharmacy 25(3): 39: 43-45